SCI Abstract

search
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study
Volume 51, Issue 6, November 2025, 101665Author links open overlay panel, , , , , Highlights•Both sugar and artificially s...
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort
Volume 51, Issue 6, November 2025, 101700Author links open overlay panel, , , , , , , , , , , , AbstractAim- To investigat...
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study
Volume 51, Issue 6, November 2025, 101703Author links open overlay panel, , , , , , , , Highlights•Remission of diabetic r...
Epicardial adipose tissue volume and diabetic retinopathy
MethodsWe used clinical data from a monocentric mixed retrospective and prospective observational study of 1093 individual...
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps
ObjectiveThis study analyzed the determinants of weight gain among participants initiating an automated insulin delivery (...
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks
Volume 51, Issue 6, November 2025, 101704Author links open overlay panel, , , , , , , , , , AbstractObjectiveSodium-glucos...
Peripheral neuropathy as a bedside marker for cerebral microangiopathy
Volume 51, Issue 6, November 2025, 101702Author links open overlay panelSection snippetsFunding sourcesNot AvailableTrial ...
Ulcer topography matters: hindfoot versus forefoot outcomes in first-time diabetic foot ulcer
Volume 51, Issue 6, November 2025, 101707Author links open overlay panelSection snippetsFunding statementThis study was co...
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations
Several comorbidities are associated with an increased risk of sarcopenia, i.e. type 2 diabetes, cardiovascular disease, h...
Handgrip strength cut-off points for identifying French adults at risk of type 2 diabetes
The increasing prevalence of diabetes among adults in both developed and low-income countries has become a major concern f...
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study
Clinical, stage 3, type 1 diabetes (T1D) is the consequence of beta-cell destruction by an auto-immune process, assumed to...
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis
Diabete mellitus (DM) is a major health issue affecting 422 million people worldwide. Among them, 20–40 % will develop a c...
Comparative study of SGLT2 inhibitors and metformin: evaluating first-line therapies for dementia prevention in type 2 diabetes
Conceptualization: Mingyang Sun, MD; Xiaoling Wang, PhD; Methodology: Zhongyuan Lu, PhD; Yitian Yang, MD, PhD; Software: S...
Hip fractures and type 2 diabetes in the elderly: risk factors analysis of the Nedices cohort
Hip fractures significantly increase the risk of mortality and morbidity in older adults. As a result, the risk factors (R...
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
Volume 51, Issue 3, May 2025, 101641Author links open overlay panel, , AbstractGlucagon-like peptide-1 (GLP-1) is an incre...
Practical implementation of automated insulin delivery systems in 2025: A French position statement update
The advent of automated insulin delivery (AID) systems in 2020 marked a disruptive event in managing type 1 diabetes, bene...
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus
Volume 51, Issue 3, May 2025, 101627Author links open overlay panel, , , , , , , Highlights•Diabetic kidney transplant rec...
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus
Volume 51, Issue 3, May 2025, 101624Author links open overlay panel, , , , , , Highlights•GLP1 receptor agonists show reno...
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide and the leadin...
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data
Early access to innovative therapies is crucial to optimize patient management, especially in rare or severe diseases wher...
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States
AimTo understand treatment patterns and effectiveness of tirzepatide among people without type 2 diabetes (T2D) in the US....